Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Ahn

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Korean Circulation Journal|May 11, 2019
Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality ImagingReza Arsanjani, Pradyumna Agasthi, Daniel H Ahn, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and valueDaniel H Ahn, Andrew H Ko, Neal J Meropol, et al.
Journal of Oncology Practice|May 2, 2013
Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factorsDaniel H Ahn, Henrik Bo Illum, David H Wang, et al.
NPJ Precision Oncology|October 11, 2018
Emerging role of precision medicine in biliary tract cancersJames M Bogenberger, Thomas T DeLeon, Mansi Arora, et al.
Cancer Treatment Reviews|December 2, 2015
Adjuvant therapy for pancreas cancer in an era of value based cancer careDaniel H Ahn, Terence M Williams, Daniel A Goldstein, et al.
Clinical Lung Cancer|July 27, 2013
Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancerDaniel H Ahn, Nishi Mehta, Jeffrey T Yorio, et al.
Oncotarget|December 20, 2015
Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitorsDaniel H Ahn, Hatice Gulcin Ozer, Baris Hancioglu, et al.
Seminars in Liver Disease|May 6, 2021
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?Pedro Luiz Serrano Uson Junior, Bolni Marius Nagalo, Daniel H Ahn, et al.
The Oncologist|August 12, 2025
Real-World Clinical Outcomes of Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Retrospective US Claims AnalysisDaniel H Ahn, Noh Jin Park, Michael Locker, et al.
Cancers|January 25, 2025
Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective StudyFarshid Dayyani, Heide A Stirnadel-Farrant, Jenny Hu, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Korean Circulation Journal|May 11, 2019
Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality ImagingReza Arsanjani, Pradyumna Agasthi, Daniel H Ahn, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and valueDaniel H Ahn, Andrew H Ko, Neal J Meropol, et al.
Journal of Oncology Practice|May 2, 2013
Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factorsDaniel H Ahn, Henrik Bo Illum, David H Wang, et al.
NPJ Precision Oncology|October 11, 2018
Emerging role of precision medicine in biliary tract cancersJames M Bogenberger, Thomas T DeLeon, Mansi Arora, et al.
Cancer Treatment Reviews|December 2, 2015
Adjuvant therapy for pancreas cancer in an era of value based cancer careDaniel H Ahn, Terence M Williams, Daniel A Goldstein, et al.
Clinical Lung Cancer|July 27, 2013
Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancerDaniel H Ahn, Nishi Mehta, Jeffrey T Yorio, et al.
Oncotarget|December 20, 2015
Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitorsDaniel H Ahn, Hatice Gulcin Ozer, Baris Hancioglu, et al.
Seminars in Liver Disease|May 6, 2021
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?Pedro Luiz Serrano Uson Junior, Bolni Marius Nagalo, Daniel H Ahn, et al.
The Oncologist|August 12, 2025
Real-World Clinical Outcomes of Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Retrospective US Claims AnalysisDaniel H Ahn, Noh Jin Park, Michael Locker, et al.
Cancers|January 25, 2025
Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective StudyFarshid Dayyani, Heide A Stirnadel-Farrant, Jenny Hu, et al.
Pageof 8